JP2008540547A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540547A5 JP2008540547A5 JP2008511281A JP2008511281A JP2008540547A5 JP 2008540547 A5 JP2008540547 A5 JP 2008540547A5 JP 2008511281 A JP2008511281 A JP 2008511281A JP 2008511281 A JP2008511281 A JP 2008511281A JP 2008540547 A5 JP2008540547 A5 JP 2008540547A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- cycloalkyl
- heterocyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 201
- 125000001072 heteroaryl group Chemical group 0.000 claims 64
- 125000003118 aryl group Chemical group 0.000 claims 63
- 125000000753 cycloalkyl group Chemical group 0.000 claims 62
- 125000000304 alkynyl group Chemical group 0.000 claims 27
- 125000003342 alkenyl group Chemical group 0.000 claims 26
- 239000001257 hydrogen Substances 0.000 claims 26
- 229910052739 hydrogen Inorganic materials 0.000 claims 26
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 24
- 125000001188 haloalkyl group Chemical group 0.000 claims 16
- 150000002431 hydrogen Chemical class 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 14
- 125000003545 alkoxy group Chemical group 0.000 claims 11
- 229910052757 nitrogen Inorganic materials 0.000 claims 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 10
- 125000000623 heterocyclic group Chemical group 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 125000005843 halogen group Chemical group 0.000 claims 6
- 125000001475 halogen functional group Chemical group 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- -1 heterocyclo Chemical group 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000002393 azetidinyl group Chemical group 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000004419 alkynylene group Chemical group 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 0 *c(c1c([n]2)nc(*)c3c1[n](*)c(*)n3)c2N=* Chemical compound *c(c1c([n]2)nc(*)c3c1[n](*)c(*)n3)c2N=* 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67969205P | 2005-05-10 | 2005-05-10 | |
| US60/679,692 | 2005-05-10 | ||
| US11/430,215 US7737279B2 (en) | 2005-05-10 | 2006-05-08 | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| US11/430,215 | 2006-05-08 | ||
| PCT/US2006/017950 WO2006122137A1 (en) | 2005-05-10 | 2006-05-09 | 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008540547A JP2008540547A (ja) | 2008-11-20 |
| JP2008540547A5 true JP2008540547A5 (cg-RX-API-DMAC7.html) | 2009-06-04 |
| JP5047164B2 JP5047164B2 (ja) | 2012-10-10 |
Family
ID=36808856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008511281A Expired - Fee Related JP5047164B2 (ja) | 2005-05-10 | 2006-05-09 | ＩＫＫ酵素活性の阻害剤としての１，６−ジヒドロ−１，３，５，６−テトラアザ−ａｓ−インダセンをベースとした三環式化合物およびそれを含む医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7737279B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1888584B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5047164B2 (cg-RX-API-DMAC7.html) |
| AR (1) | AR053725A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE465162T1 (cg-RX-API-DMAC7.html) |
| CY (1) | CY1110419T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602006013816D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1888584T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2342976T3 (cg-RX-API-DMAC7.html) |
| PE (1) | PE20061424A1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1888584T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1888584E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1888584T1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200718422A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006122137A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7737279B2 (en) * | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| KR20110017431A (ko) | 2008-06-10 | 2011-02-21 | 아보트 러보러터리즈 | 신규한 트리사이클릭 화합물 |
| SI2473510T1 (sl) | 2009-09-03 | 2014-10-30 | Bristol-Myers Squibb Company | Jak2 inhibitorji in njihova uporaba za zdravljenje mieloproliferativnih bolezni in raka |
| NZ599938A (en) | 2009-12-01 | 2014-08-29 | Abbvie Inc | Novel tricyclic compounds |
| TWI500620B (zh) * | 2009-12-01 | 2015-09-21 | Abbvie Inc | 新穎三環化合物 |
| US8461328B2 (en) * | 2010-01-12 | 2013-06-11 | Genentech, Inc. | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| WO2011112687A2 (en) * | 2010-03-10 | 2011-09-15 | Kalypsys, Inc. | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| EA201492223A1 (ru) | 2012-06-13 | 2015-03-31 | Ф. Хоффманн-Ля Рош Аг | Новые диазаспироциклоалканы и азаспироциклоалканы |
| PL2900669T3 (pl) | 2012-09-25 | 2020-01-31 | F. Hoffmann-La Roche Ag | Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| US9518058B2 (en) | 2013-08-29 | 2016-12-13 | Bristol-Myers Squibb Company | Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide |
| EP3061754A4 (en) | 2013-10-23 | 2017-03-22 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| UA118201C2 (uk) | 2013-11-26 | 2018-12-10 | Ф. Хоффманн-Ля Рош Аг | НОВИЙ ОКТАГІДРОЦИКЛОБУТА[1,2-c;3,4-c']ДИПІРОЛ-2-ІЛ |
| SG11201607839UA (en) | 2014-03-26 | 2016-10-28 | Hoffmann La Roche | Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| CR20160418A (es) | 2014-03-26 | 2016-11-07 | Hoffmann La Roche | Nuevos compuestos biciclicos de 7 eslabones |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| MX387736B (es) | 2015-09-04 | 2025-03-18 | Hoffmann La Roche | Derivados de fenoximetilo. |
| AU2016328365B2 (en) | 2015-09-24 | 2020-04-23 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
| WO2017050732A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
| AU2016328436B2 (en) | 2015-09-24 | 2020-05-14 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
| MA42919A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| CA3251507A1 (en) | 2015-10-16 | 2025-05-21 | Abbvie Inc. | Use of a solid dosage form comprising (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide for treating rheumatoid arthritis |
| US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US12365689B2 (en) | 2015-10-16 | 2025-07-22 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| CA3033752C (en) * | 2016-08-15 | 2022-05-31 | Purdue Research Foundation | 4-substituted aminoisoquinoline derivatives |
| EP4086256A1 (en) | 2016-12-16 | 2022-11-09 | Janssen Pharmaceutica NV | Small molecule inhibitors of the jak family of kinases |
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
| CR20190423A (es) | 2017-03-16 | 2019-11-01 | Hoffmann La Roche | Nuevos compuestos biciclícos como inhibidores dobles de atx/ca |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| JP2023544678A (ja) * | 2020-10-08 | 2023-10-25 | ユニケム ラボラトリーズ リミテッド | 置換三環系化合物 |
| CN116507627A (zh) | 2020-11-02 | 2023-07-28 | 勃林格殷格翰国际有限公司 | 作为egfr抑制剂的经取代1h-吡唑并[4,3-c]吡啶及衍生物 |
| CA3213134A1 (en) | 2021-03-11 | 2022-09-15 | Janssen Pharmaceutica Nv | Lorpucitinib for use in the treatment of jak mediated disorders |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU651569B2 (en) | 1990-01-11 | 1994-07-28 | Isis Pharmaceuticals, Inc. | Compositions and methods for detecting and modulating RNA activity and gene expression |
| EP1060181B1 (en) | 1998-02-26 | 2004-05-06 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| TWI271406B (en) * | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| US6653471B2 (en) | 2000-08-07 | 2003-11-25 | Neurogen Corporation | Heterocyclic compounds as ligands of the GABAA receptor |
| AU2003222106A1 (en) | 2002-04-03 | 2003-10-20 | Bristol-Myers Squibb Company | Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same |
| US7329668B2 (en) | 2003-02-25 | 2008-02-12 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| US7176214B2 (en) | 2003-05-21 | 2007-02-13 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| US7071333B2 (en) | 2003-07-30 | 2006-07-04 | Bristol-Myers Squibb Company | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| AU2004266657B2 (en) * | 2003-08-14 | 2009-07-02 | 3M Innovative Properties Company | Lipid-modified immune response modifiers |
| GB0403635D0 (en) | 2004-02-18 | 2004-03-24 | Devgen Nv | Pyridinocarboxamides with improved activity as kinase inhibitors |
| WO2005105788A1 (en) | 2004-04-23 | 2005-11-10 | Takeda San Diego, Inc. | Indole derivatives and use thereof as kinase inhibitors |
| US7557211B2 (en) | 2004-11-12 | 2009-07-07 | Bristol-Myers Squibb Company | 8H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| US7456194B2 (en) | 2004-11-12 | 2008-11-25 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| US7737279B2 (en) * | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
-
2006
- 2006-05-08 US US11/430,215 patent/US7737279B2/en active Active
- 2006-05-09 AT AT06759417T patent/ATE465162T1/de active
- 2006-05-09 PL PL06759417T patent/PL1888584T3/pl unknown
- 2006-05-09 PT PT06759417T patent/PT1888584E/pt unknown
- 2006-05-09 JP JP2008511281A patent/JP5047164B2/ja not_active Expired - Fee Related
- 2006-05-09 ES ES06759417T patent/ES2342976T3/es active Active
- 2006-05-09 EP EP06759417A patent/EP1888584B1/en not_active Not-in-force
- 2006-05-09 WO PCT/US2006/017950 patent/WO2006122137A1/en not_active Ceased
- 2006-05-09 DE DE602006013816T patent/DE602006013816D1/de active Active
- 2006-05-09 SI SI200630671T patent/SI1888584T1/sl unknown
- 2006-05-09 DK DK06759417.6T patent/DK1888584T3/da active
- 2006-05-10 TW TW095116493A patent/TW200718422A/zh unknown
- 2006-05-10 PE PE2006000492A patent/PE20061424A1/es not_active Application Discontinuation
- 2006-05-10 AR ARP060101882A patent/AR053725A1/es not_active Application Discontinuation
-
2010
- 2010-04-23 US US12/765,932 patent/US8268855B2/en active Active
- 2010-07-19 CY CY20101100670T patent/CY1110419T1/el unknown